DAP:ETR
Danaher Corp
€ २०८.८०
arrow_upward
+०.४३%(+०.९०) 1D
अक्टोबर २२, १७:३५:३९ GMT+२ · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for DAP...
Open
€ २०८.६०
High
€ २१०.३०
Low
€ २०६.००
Mkt. cap
१.६२ खरब
Avg. vol.
५१९.००
Volume
२६०.००
52-wk high
€ २१०.३०
52-wk low
€ १३८.२०
No. of employees
५९ हजार
Open
€ २०८.६०
High
€ २१०.३०
Low
€ २०६.००
Mkt. cap
१.६२ खरब
Avg. vol.
५१९.००
Volume
२६०.००
52-wk high
€ २१०.३०
52-wk low
€ १३८.२०
No. of employees
५९ हजार
News stories
From web sources and news partners
Investing.com
·
३ घण्टा पहिले
UBS reiterates Danaher stock Buy rating on Q3 results and outlook
Yahoo Finance
·
६ घण्टा पहिले
Danaher (DHR) Q3 Earnings Fuel Stock Gains On Margin Expansion
finchannel
·
१० घण्टा पहिले
Danaher raises 2026 earnings outlook as quarterly revenue grows 8.5%
MarketWatch
·
२१ घण्टा पहिले
Danaher Corp. stock outperforms competitors on strong trading day
Profile
Danaher Corporation is an American healthcare company headquartered in Washington, D.C.. It develops products used for advances in biotechnology, life sciences, and diagnostics. The company operates three divisions: biotechnology, which develops products for the development of therapeutics; life sciences, which develops products to identify causes of disease, new therapies, and to test and manufacture new drugs, vaccines and gene editing technologies; and diagnostics, which develops instruments, consumables, and software and services to diagnose diseases. Danaher was founded in 1984 by brothers Steven Rales and Mitchell Rales; it was named after Danaher Creek in Western Montana, where the brothers came up with the idea for the company while fishing.
The company is ranked 180th on the Fortune 500 and 241st on the Forbes Global 2000. Wikipedia
About Danaher Corp